The DOI matches its Crossref record; 67 of the 70 references it cites were found in a registry or an index.
Aβ Oligomers Cause Localized Ca 2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines
Open accessAbstract
Aggregation of amyloid-β (Aβ) and Tau protein are hallmarks of Alzheimer's disease (AD), and according to the Aβ-cascade hypothesis, Aβ is considered toxic for neurons and Tau a downstream target of Aβ. We have investigated differentiated primary hippocampal neurons for early localized changes following exposure to Aβ oligomers. Initial events become evident by missorting of endogenous Tau into the somatodendritic compartment, in contrast to axonal sorting in normal neurons. In missorted dendritic regions there is a depletion of spines and local increase in Ca 2+ , and breakdown of microtubules. Tau in these regions shows elevated phosphorylation at certain sites diagnostic of AD-Tau (e.g., epitope of antibody 12E8, whose phosphorylation causes detachment of Tau from microtubules, and AT8 epitope), and local elevation of certain kinase activities (e.g., MARK/par-1, BRSK/SADK, p70S6K, cdk5, but not GSK3β, JNK, MAPK). These local effects occur without global changes in Tau, tubulin, or kinase levels. Somatodendritic missorting occurs not only with Tau, but also with other axonal proteins such as neurofilaments, and correlates with pronounced depletion of microtubules and mitochondria. The Aβ-induced effects on microtubule and mitochondria depletion, Tau missorting, and loss of spines are prevented by taxol, indicating that Aβ-induced microtubule destabilization and corresponding traffic defects are key factors in incipient degeneration. By contrast, the rise in Ca 2+ levels, kinase activities, and Tau phosphorylation cannot be prevented by taxol. Incipient and local changes similar to those of Aβ oligomers can be evoked by cell stressors (e.g., H 2 O 2 , glutamate, serum deprivation), suggesting some common mechanism of signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“mis-localization to dendrites and spines causing neurotoxicity [52]”
From Astrocytic APOE3-Christchurch expression ameliorates brain amyloid-β pathology in 5xFAD mice (2026) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Under normal conditions, tau is primarily localized to axons and promotes formation and stabilization of microtubules; however, in AD, tau becomes hyperphosphorylated and mislocalizes to somatodendritic compartments (Avila et al., 2004, Ittner et al., 2010, Zempel et al., 2010).”
From Dendritic Spine Remodeling and Synaptic Tau Levels in PS19 Tauopathy Mice (2021) · cites this paper as Zempel et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the activities of two major tau kinases, GSK3 and PAR-1/microtubule affinity-regulating kinases (MARKs), are often associated with tau detachment from microtubules and Aβ-induced augmentation of tau toxicity [37, 39, 43–45].”
From Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity (2016) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, studies in cultured neurons and transgenic Drosophila showed that Aβ-induced augmentation of tau toxicity caused by Aβ depends on tau phosphorylation at these sites [39, 45, 56–58].”
From Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity (2016) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Aβ promotes tau phosphorylation at disease-associated sites in in vitro and in vivo models of AD [2, 35–41].”
From Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity (2016) · cites this paper as [39]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In cellular and animal models, co-expression of Aβ augments tau phosphorylation at these sites and increases the levels of active GSK3 and PAR-1/MARK [2, 35–41, 43, 44].”
From Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity (2016) · cites this paper as [39]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Ab oligomers also cause tau mislocalization (77,78).”
The cited source says what the claim attributes to it.
In the citing paper
“Under normal conditions, tau is primarily localized to axons and promotes formation and stabilization of microtubules; however, in AD, tau becomes hyperphosphorylated and mislocalizes to somatodendritic compartments (Avila et al., 2004, Ittner et al., 2010, Zempel et al., 2010).”
From Dendritic Spine Remodeling and Synaptic Tau Levels in PS19 Tauopathy Mice (2021) · cites this paper as Zempel et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“We also note that in our preparations we did not consistently observe a band at 56 kDa, a species that has been reported to be toxic for transgenic mice (Lesné et al., 2006) but can be visualized in certain conditions (Walsh et al., 2005; Ashe, 2006; Bernstein et al., 2009).”
BackgroundRetractedSoluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 1×
“Despite numerous studies on the pathway of APP misprocessing and its consequences for neurons the modes of A toxicity have remained enigmatic (Haass and Selkoe, 2007; Small and Duff, 2008).”
BackgroundCommon structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · cited 1×
“Nevertheless, there were differences in structure because dot blots with antibody A11, which recognizes a more toxic generic amyloid conformation (Kayed et al., 2003), were more intense for F12 medium than for Nb (Fig.”
BackgroundDiffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · cited 3×
“There is a moderate decrease of ATP which is more apparent with F12 than with Nb medium, suggesting that F12, which was used in the original procedure (Lambert et al., 1998), could have some toxic effects on its own.”
BackgroundMethodTau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174 · cited 1×
“These include loss of synapses and neurons, deficiency in neurotransmitters and metabolism, aggregation of amyloid- (A )-peptides into extracellular “amyloid plaques” and Tau protein into intracellular “neurofibrillary tangles” (Selkoe, 2004; Binder et al., 2005; Ballatore et al., 2007).”
BackgroundReducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892 · cited 1×
“…conversely Tau is considered necessary for the progression of neurodegeneration, as seen in cell and animal models (Rapoport et al., 2002; King et al., 2006; Roberson et al., 2007), and indeed the Tau pathology correlates well with clinical symptoms (Braak and Braak, 1991; Clavaguera et al., 2009).”
BackgroundTransmission and spreading of tauopathy in transgenic mouse brain
Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1901 · Cited by 1,803
Physiology and Pathophysiology of Purinergic Neurotransmission
Burnstock, G. (2007) · Physiological Reviews · doi:10.1152/physrev.00043.2006 · Cited by 1,609 · cited 1×
“We also tested extracellular ATP (100 M, 3 h), which functions as a stress signal and induces Ca 2 influx via P2 receptors and has been implicated in neurodegenerative disease (Burnstock, 2007).”
MethodShankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592 · cited 1×
“4e,f), and involving NMDA receptors and others (De Felice et al., 2007; Shankar et al., 2007).”
BackgroundThe axonal transport of mitochondria
Saxton, W. M., & Hollenbeck, P. J. (2012) · Journal of Cell Science · doi:10.1242/jcs.053850 · Cited by 1,218 · cited 1×
“As shown previously (Stamer et al., 2002; Hollenbeck and Saxton, 2005; Thies and Mandelkow, 2007), such mitochondrial traffic jams cause a local drop of energy (ATP) and consequently spine destruction through the perturbation of the actin network and loss of synaptic components (Whiteman et al.,…”
BackgroundPain: Moving from Symptom Control toward Mechanism-Specific Pharmacologic Management
Woolf, C. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-8-200404200-00010 · Cited by 1,134
Microtubule assembly, organization and dynamics in axons and dendrites
Conde, C., & Cáceres, A. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2631 · Cited by 1,086 · cited 1×
“In addition a change in MT dynamics alters their posttranslational modifications and thus perturbs polarized trafficking of cargo (Li and Gundersen, 2008; Conde and Cáceres, 2009; Konishi and Setou, 2009).”
BackgroundBernstein, S. L., Dupuis, N., Lazo, N. D., Wyttenbach, T., Condron, M. M., Bitan, G., Teplow, D. B., Shea, J., Ruotolo, B. T., Robinson, C. V., et al. (2009) · Nature Chemistry · doi:10.1038/nchem.247 · Cited by 943 · cited 1×
“We also note that in our preparations we did not consistently observe a band at 56 kDa, a species that has been reported to be toxic for transgenic mice (Lesné et al., 2006) but can be visualized in certain conditions (Walsh et al., 2005; Ashe, 2006; Bernstein et al., 2009).”
BackgroundNeurotoxicity of a Fragment of the Amyloid Precursor Associated with Alzheimer's Disease
Yankner, B. A., Dawes, L. R., Fisher, S., Villa-Komaroff, L., Oster-Granite, M. L., & Neve, R. L. (1989) · Science · doi:10.1126/science.2474201 · Cited by 907 · cited 2×
“Previous studies have focused primarily on global effects of A on changes in Tau (e.g., phosphorylation, cleavage) and resulting cell death (Yankner et al., 1989; Mattson, 1990; Busciglio et al., 1995; Park and Ferreira, 2005; King et al., 2006), with less attention to the localized changes due to…”
BackgroundStamer, K., Vogel, R., Thies, E., Mandelkow, E., & Mandelkow, E.-M. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108057 · Cited by 885 · cited 2×
“As shown previously (Stamer et al., 2002; Hollenbeck and Saxton, 2005; Thies and Mandelkow, 2007), such mitochondrial traffic jams cause a local drop of energy (ATP) and consequently spine destruction through the perturbation of the actin network and loss of synaptic components (Whiteman et al.,…”
BackgroundSelf-citationDe Felice, F. G., Velasco, P. T., Lambert, M. P., Viola, K., Fernandez, S. J., Ferreira, S. T., & Klein, W. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607483200 · Cited by 882 · cited 1×
“4e,f), and involving NMDA receptors and others (De Felice et al., 2007; Shankar et al., 2007).”
BackgroundThe Mechanism of Ca2+-Dependent Regulation of Kinesin-Mediated Mitochondrial Motility
Wang, X., & Schwarz, T. L. (2009) · Cell · doi:10.1016/j.cell.2008.11.046 · Cited by 871 · cited 2×
“Thirdly, Ca 2 uncouples mitochondrial motors from microtubule tracks (Wang and Schwarz, 2009).”
BackgroundTau is essential to β-amyloid-induced neurotoxicity
Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., & Ferreira, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092136199 · Cited by 807 · cited 1×
“…upstream of changes in Tau, but conversely Tau is considered necessary for the progression of neurodegeneration, as seen in cell and animal models (Rapoport et al., 2002; King et al., 2006; Roberson et al., 2007), and indeed the Tau pathology correlates well with clinical symptoms (Braak and…”
BackgroundStructural Classification of Toxic Amyloid Oligomers
Glabe, C. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800016200 · Cited by 783 · cited 5×
“On the SDS gels, the different media (F12 or Nb) yielded similar bands, with the caveat that these gels can obscure the coexistence of multiple oligomeric species (Glabe, 2008).”
BackgroundInfluentialStructure–neurotoxicity relationships of amyloid β-protein oligomers
Ono, K., Condron, M. M., & Teplow, D. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905127106 · Cited by 782 · cited 2×
“We note that, apart from its minor amount, the fiber component would be of lesser importance since its toxicity is lower than that of oligomers (Klein et al., 2004; Ono et al., 2009).”
BackgroundResultKöpke, E., Tung, Y. C., Shaikh, S., Alonso, A. C., Iqbal, K., & Grundke-Iqbal, I. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80536-5 · Cited by 779
Kayed, R., Head, E., Sarsoza, F., Saing, T., Cotman, C. W., Necula, M., Margol, L., Wu, J., Breydo, L., Thompson, J. L., et al. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-18 · Cited by 773
Mattson, M. P. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00275.x · Cited by 751 · cited 2×
“, proteasome, mitochondria) and perturbation of calcium homeostasis (Mattson, 2007).”
BackgroundAnimal models of Alzheimer's disease and frontotemporal dementia
Götz, J., & Ittner, L. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2420 · Cited by 676 · cited 2×
“Examples of local effects are the early loss of synapses and the appearance of Tau in somata and dendrites (Götz and Ittner, 2008).”
BackgroundDemonstration of amyloid deposits and neurofibrillary changes in whole brain sections
Braak, H., & Braak, E. (1991) · Brain Pathology · doi:10.1111/j.1750-3639.1991.tb00661.x · Cited by 598 · cited 2×
“The neurofibrillary changes follow a typical pathway of spreading which corresponds to clinical symptoms, hence Tau pathology is considered as one of the culprits in the disease (Braak and Braak, 1991; Spires-Jones et al., 2009).”
Backgroundβ-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding
Busciglio, J., Lorenzo, A., Yeh, J., & Yankner, B. A. (1995) · Neuron · doi:10.1016/0896-6273(95)90232-5 · Cited by 595 · cited 1×
“…focused primarily on global effects of A on changes in Tau (e.g., phosphorylation, cleavage) and resulting cell death (Yankner et al., 1989; Mattson, 1990; Busciglio et al., 1995; Park and Ferreira, 2005; King et al., 2006), with less attention to the localized changes due to Tau redistribution.”
BackgroundLinking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis
Small, S. A., & Duff, K. (2008) · Neuron · doi:10.1016/j.neuron.2008.11.007 · Cited by 546 · cited 1×
“Despite numerous studies on the pathway of APP misprocessing and its consequences for neurons the modes of A toxicity have remained enigmatic (Haass and Selkoe, 2007; Small and Duff, 2008).”
BackgroundKlein, W. L., Stine, W. B., & Teplow, D. B. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.010 · Cited by 494 · cited 3×
“We note that, apart from its minor amount, the fiber component would be of lesser importance since its toxicity is lower than that of oligomers (Klein et al., 2004; Ono et al., 2009).”
BackgroundMethodIntroducing intermediate filaments: from discovery to disease.
Eriksson, J., Dechat, T., Grin, B., Helfand, B., Mendez, M. G., Pallari, H.-M., & Goldman, R. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38339 · Cited by 463 · cited 1×
“An additional function of microtubules is to subtend cellular networks such as the ER and intermediate filament network, so that these networks collapse when microtubules or motors are inactivated or reversed in direction (Stamer et al., 2002; Eriksson et al., 2009).”
BackgroundTau, tangles, and Alzheimer's disease
Binder, L. I., Guillozet-Bongaarts, A. L., García‐Sierra, F., & Berry, R. W. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.08.014 · Cited by 450 · cited 1×
“These include loss of synapses and neurons, deficiency in neurotransmitters and metabolism, aggregation of amyloid- (A )-peptides into extracellular “amyloid plaques” and Tau protein into intracellular “neurofibrillary tangles” (Selkoe, 2004; Binder et al., 2005; Ballatore et al., 2007).”
BackgroundZhang, B., Maiti, A., Shively, S., Lakhani, F., McDonald-Jones, G., Bruce, J., Lee, E. B., Xie, S. X., Joyce, S., Li, C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406361102 · Cited by 413 · cited 1×
“Lowering cytosolic Ca 2 would appear as prime target for intervention, but the decay of microtubules seems more targetable through microtubulestabilizing drugs (Mattson, 1992; Michaelis et al., 2005; Zhang et al., 2005).”
BackgroundBeyond polymer polarity: how the cytoskeleton builds a polarized cell
Li, R., & Gundersen, G. G. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2522 · Cited by 407 · cited 1×
“In addition a change in MT dynamics alters their posttranslational modifications and thus perturbs polarized trafficking of cargo (Li and Gundersen, 2008; Conde and Cáceres, 2009; Konishi and Setou, 2009).”
BackgroundTubulin tyrosination navigates the kinesin-1 motor domain to axons
Konishi, Y., & Setou, M. (2009) · Nature Neuroscience · doi:10.1038/nn.2314 · Cited by 403 · cited 1×
“In addition a change in MT dynamics alters their posttranslational modifications and thus perturbs polarized trafficking of cargo (Li and Gundersen, 2008; Conde and Cáceres, 2009; Konishi and Setou, 2009).”
BackgroundWu, H.-Y., Hudry, E., Hashimoto, T., Kuchibhotla, K., Rozkalne, A., Fan, Z., Spires-Jones, T., Xie, H., Arbel-Ornath, M., Grosskreutz, C. L., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4456-09.2010 · Cited by 367 · cited 1×
“This could explain the increase in activity of MARK, cdk5 and others; for example, CaMK-I activates MARK2 and this pathway contributes to neuronal differentiation (Biernat et al., 2002; Uboha et al., 2007; He et al., 2008; Wu et al., 2010).”
BackgroundMammalian SAD Kinases Are Required for Neuronal Polarization
Kishi, M., Pan, Y. A., Crump, J. G., & Sanes, J. R. (2005) · Science · doi:10.1126/science.1107403 · Cited by 345 · cited 1×
“6c); this kinase, like MARK, is involved in axonal differentiation (Kishi et al., 2005) and also belongs to the AMPK family of kinases.”
BackgroundTau pathophysiology in neurodegeneration: a tangled issue
Spires‐Jones, T. L., Stoothoff, W. H., de Calignon, A., Jones, P., & Hyman, B. T. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.11.007 · Cited by 321 · cited 1×
“The neurofibrillary changes follow a typical pathway of spreading which corresponds to clinical symptoms, hence Tau pathology is considered as one of the culprits in the disease (Braak and Braak, 1991; Spires-Jones et al., 2009).”
BackgroundThies, E., & Mandelkow, E.-M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4674-06.2007 · Cited by 293 · cited 3×
“Earlier experiments with overexpressed Tau had shown that dendritic Tau can cause traffic jams, resulting in transport inhibition of vesicles and organelles (e.g., mito- chondria), loss of ATP supply, and decay of synaptic spines (Thies and Mandelkow, 2007).”
BackgroundSelf-citationMattson, M. (1990) · Neuron · doi:10.1016/0896-6273(90)90447-n · Cited by 292 · cited 1×
“…have focused primarily on global effects of A on changes in Tau (e.g., phosphorylation, cleavage) and resulting cell death (Yankner et al., 1989; Mattson, 1990; Busciglio et al., 1995; Park and Ferreira, 2005; King et al., 2006), with less attention to the localized changes due to Tau…”
BackgroundProtein Kinase MARK/PAR-1 Is Required for Neurite Outgrowth and Establishment of Neuronal Polarity
Biernat, J., Wu, Y.-Z., Timm, T., Zheng-Fischhöfer, Q., Mandelkow, E., Meijer, L., & Mandelkow, E.-M. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.02-03-0046 · Cited by 279 · cited 1×
“This could explain the increase in activity of MARK, cdk5 and others; for example, CaMK-I activates MARK2 and this pathway contributes to neuronal differentiation (Biernat et al., 2002; Uboha et al., 2007; He et al., 2008; Wu et al., 2010).”
BackgroundSelf-citationPark, S.-Y., & Ferreira, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1125-05.2005 · Cited by 262 · cited 1×
“…focused primarily on global effects of A on changes in Tau (e.g., phosphorylation, cleavage) and resulting cell death (Yankner et al., 1989; Mattson, 1990; Busciglio et al., 1995; Park and Ferreira, 2005; King et al., 2006), with less attention to the localized changes due to Tau redistribution.”
BackgroundCalcium lability of cytoplasmic microtubules and its modulation by microtubule-associated proteins.
Schliwa, M., Euteneuer, U., Bulinski, J. C., & Izant, J. G. (1981) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.78.2.1037 · Cited by 239 · cited 3×
“and promotes their disassembly (Schliwa et al., 1981); this mechanism operates in addition to the Ca 2 -CaM-dependent”
BackgroundMethodInfluentialAlzheimer Disease: Mechanistic Understanding Predicts Novel Therapies
Selkoe, D. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-8-200404200-00046 · Cited by 234 · cited 1×
“These include loss of synapses and neurons, deficiency in neurotransmitters and metabolism, aggregation of amyloid- (A )-peptides into extracellular “amyloid plaques” and Tau protein into intracellular “neurofibrillary tangles” (Selkoe, 2004; Binder et al., 2005; Ballatore et al., 2007).”
BackgroundWogulis, M., Wright, S., Cunningham, D., Chilcote, T., Powell, K., & Rydel, R. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2381-04.2005 · Cited by 233 · cited 2×
“This can be done in a variety of ways, and there is a debate on which is most appropriate for assessing A toxicity (Wogulis et al., 2005).”
BackgroundWalsh, D. M., Klyubin, I., Shankar, G. M., Townsend, M., Fadeeva, J. V., Betts, V., Podlisny, M. B., Cleary, J. P., Ashe, K. H., Rowan, M. J., et al. (2005) · Biochemical Society Transactions · doi:10.1042/bst20051087 · Cited by 222 · cited 1×
“We also note that in our preparations we did not consistently observe a band at 56 kDa, a species that has been reported to be toxic for transgenic mice (Lesné et al., 2006) but can be visualized in certain conditions (Walsh et al., 2005; Ashe, 2006; Bernstein et al., 2009).”
BackgroundTau-dependent microtubule disassembly initiated by prefibrillar β-amyloid
King, M. E., Kan, H.-M., Baas, P. W., Erişir, A., Glabe, C. G., & Bloom, G. S. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200605187 · Cited by 215 · cited 2×
“…Tau, but conversely Tau is considered necessary for the progression of neurodegeneration, as seen in cell and animal models (Rapoport et al., 2002; King et al., 2006; Roberson et al., 2007), and indeed the Tau pathology correlates well with clinical symptoms (Braak and Braak, 1991; Clavaguera et…”
BackgroundLovell, M. A., Xiong, S., Xie, C., Davies, P., & Markesbery, W. R. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6610 · Cited by 212 · cited 1×
“The results have not been uniform; increases in Tau phosphorylation have been observed in some cases, not in others (Davis et al., 1997; Lovell et al., 2004; Su et al., 2010).”
ResultChronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells
Su, B., Wang, X., Lee, H., Tabaton, M., Perry, G. L., Smith, M. A., & Zhu, X. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.010 · Cited by 186 · cited 1×
“The results have not been uniform; increases in Tau phosphorylation have been observed in some cases, not in others (Davis et al., 1997; Lovell et al., 2004; Su et al., 2010).”
ResultSwimming against the Tide: Mobility of the Microtubule-Associated Protein Tau in Neurons
Konzack, S., Thies, E., Marx, A., Mandelkow, E., & Mandelkow�, E. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0927-07.2007 · Cited by 165 · cited 3×
“This type of phosphorylation causes the detachment of Tau from microtubules, makes them dynamic, and renders Tau highly diffusible and able to enter dendrites (Konzack et al., 2007).”
BackgroundInfluentialSelf-citationSynaptic targeting by Aβ oligomers (ADDLS) as a basis for memory loss in early Alzheimer's disease
Klein, W. L. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2005.11.003 · Cited by 109 · cited 2×
“Part of the problem is the definition of the toxic state of A , which may be monomeric, oligomeric (currently favored), or fibrillar (formerly favored) (Klein, 2006; Glabe, 2008; Roychaudhuri et al., 2009).”
BackgroundTimm, T., Balusamy, K., Li, X., Biernat, J., Mandelkow, E., & Mandelkow, E.-M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706596200 · Cited by 95 · cited 1×
“…polyclonal amyloid- (Cell Signaling Technology; 1:200); mAb 12E8 (1:500); mAb AT8 (1:100); polyclonal MARK phospho-T208 [prepared as described by Timm et al. (2008); 1:100]; phosphop70S6Kinase (pT389, clone 108D2, Cell Signaling Technology; 1:50); polyclonal BRSK1 (Acris, 1:100); phospho-MAPK…”
Self-citationWhiteman, I. T., Gervasio, O. L., Cullen, K. M., Guillemin, G. J., Jeong, E. V., Witting, P. K., Antao, S. T., Minamide, L. S., Bamburg, J. R., & Goldsbury, C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3531-09.2009 · Cited by 92 · cited 2×
“…previously (Stamer et al., 2002; Hollenbeck and Saxton, 2005; Thies and Mandelkow, 2007), such mitochondrial traffic jams cause a local drop of energy (ATP) and consequently spine destruction through the perturbation of the actin network and loss of synaptic components (Whiteman et al., 2009).”
BackgroundMichaelis, M. L., Ansar, S., Chen, Y., Reiff, E. R., Seyb, K. I., Himes, R. H., Audus, K. L., & Georg, G. I. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.074450 · Cited by 91 · cited 1×
“Lowering cytosolic Ca 2 would appear as prime target for intervention, but the decay of microtubules seems more targetable through microtubulestabilizing drugs (Mattson, 1992; Michaelis et al., 2005; Zhang et al., 2005).”
BackgroundPirttilä, T., Kim, K. S., Mehta, P. D., Frey, H., & Wı́sniewski, H. M. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90140-6 · Cited by 79 · cited 1×
“1b), whereas the general A antibody 6E10 (Pirttilä et al., 1994; Jung et al., 1999) reacted independently of the medium.”
BackgroundFalk, T., Zhang, S., & Sherman, S. J. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-49 · Cited by 72
Uboha, N. V., Flajolet, M., Nairn, A. C., & Picciotto, M. R. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0725-07.2007 · Cited by 71 · cited 1×
“This could explain the increase in activity of MARK, cdk5 and others; for example, CaMK-I activates MARK2 and this pathway contributes to neuronal differentiation (Biernat et al., 2002; Uboha et al., 2007; He et al., 2008; Wu et al., 2010).”
BackgroundTau phosphorylation and proteolysis: Insights and perspectives
Johnson, G. V. W. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s326 · Cited by 69 · cited 1×
“With regard to proline-directed kinases we tested MAPK, JNK, cdk5, and GSK3b, all considered to be involved in the pathological phosphorylation of Tau (Johnson, 2006).”
MethodMattson, M. (1992) · Brain Research · doi:10.1016/0006-8993(92)90323-2 · Cited by 67 · cited 1×
“Lowering cytosolic Ca 2 would appear as prime target for intervention, but the decay of microtubules seems more targetable through microtubulestabilizing drugs (Mattson, 1992; Michaelis et al., 2005; Zhang et al., 2005).”
BackgroundA high-affinity protein stain for western blots, tissue prints, and electrophoretic gels.
Bickar, D., & Reid, P. D. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90049-d · Cited by 56 · cited 1×
“To confirm equal loading and successful blotting membranes were routinely stained using the CPTS staining method (Bickar and Reid, 1992), followed by standard Western blot procedure.”
MethodOxidative Stress Induces Dephosphorylation of τ in Rat Brain Primary Neuronal Cultures
Davis, D. R., Anderton, B., Brion, J., Reynolds, C., & Hanger, D. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68041590.x · Cited by 53
Minniti, A. N., Rebolledo, D. L., Grez, P. M., Fadić, R., Aldunate, R., Volitakis, I., Cherny, R. A., Opazo, C., Masters, C. L., Bush, A. I., et al. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-2 · Cited by 46 · cited 1×
“Glabe, University of California, Irvine, CA), that shows high specificity to amyloid oligomers (Kayed et al., 2007).”
BackgroundProteasome-mediated effects on amyloid precursor protein processing at the γ-secretase site
Flood, F., MURPHY, S., Cowburn, R. F., Lannfelt, L., Walker, B., & Johnston, J. A. (2005) · Biochemical Journal · doi:10.1042/bj20041145 · Cited by 40 · cited 1×
“Proteasome activity was determined following (Flood et al., 2005).”
Axon degeneration: Mechanisms and implications of a distinct program from cell death
Yan, T., Feng, Y., & Zhai, Q. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.01.013 · Cited by 36 · cited 1×
“Given this localized loss of microtubules, we hypothesized that this might lead to an impairment of mitochondrial trafficking with local dendritic energy deprivation (Yan et al., 2010).”
BackgroundCalmodulin Binding and Cdk5 Phosphorylation of p35 Regulate Its Effect on Microtubules*
He, L., Hou, Z., & Qi, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706937200 · Cited by 33 · cited 1×
“This could explain the increase in activity of MARK, cdk5 and others; for example, CaMK-I activates MARK2 and this pathway contributes to neuronal differentiation (Biernat et al., 2002; Uboha et al., 2007; He et al., 2008; Wu et al., 2010).”
Backgroundβ-Amyloid precursor protein is detectable on monocytes and is increased in Alzheimer’s disease
Jung, S. S., Gauthier, S. G., & Cashman, N. R. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00051-2 · Cited by 31 · cited 1×
“1b), whereas the general A antibody 6E10 (Pirttilä et al., 1994; Jung et al., 1999) reacted independently of the medium.”
BackgroundFeinstein, S. (2005) · doi:10.3410/f.1024510.289727 · Cited by 17 · cited 1×
“Lowering cytosolic Ca 2 would appear as prime target for intervention, but the decay of microtubules seems more targetable through microtubulestabilizing drugs (Mattson, 1992; Michaelis et al., 2005; Zhang et al., 2005).”
BackgroundIn Search of the Molecular Basis of Memory Loss in Alzheimer Disease
Ashe, K. H. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213847.66742.d9 · Cited by 7 · cited 2×
“We also note that in our preparations we did not consistently observe a band at 56 kDa, a species that has been reported to be toxic for transgenic mice (Lesné et al., 2006) but can be visualized in certain conditions (Walsh et al., 2005; Ashe, 2006; Bernstein et al., 2009).”
BackgroundS3‐03‐05: Transmission and Spreading of Tauopathy in Transgenic Mouse Brain
Tolnay, M. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.2444 · cited 2×
“, 2007), and indeed the Tau pathology correlates well with clinical symptoms (Braak and Braak, 1991; Clavaguera et al., 2009).”
Background
Research works printed but not linked: 3
- 10.1242/jcs.02745 · DOI · Paper page
- 10.1074/jbc.R800036200 · DOI
- 10.1186/1750-1326-4-48 · DOI · Paper page
Cited by
Sorted by citations
Alzheimer's DiseasePreprint
Selkoe, D. J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004457 · Cited by 383
“Many studies employing supraphysiological concentrations of synthetic Ab peptides in oligomeric form (generally larger than dimers/ trimers) have also provided evidence of tau alteration (Zempel et al. 2010) and various neurotoxic effects.”
BackgroundAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345
Bloom (2014) · doi:10.1001/jamaneurol.2013.5847 · Cited by 2,194
Tau in physiology and pathology
Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251
Self-citation
Metadata
- Authors
- Zempel, H., Thies, E., Mandelkow, E., & Mandelkow, E.-M.
- Affiliations
- Max Planck Unit for Structural Molecular Biology (DE)
- German Center for Neurodegenerative Diseases (DE)
- Corresponding author
- Mandelkow, Eva-Maria
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2010-09-08
- Volume
- 30
- Issue
- 36
- Pages
- 11938-11950
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6633549
- OpenAlex
- W2041956586
- Cited by
- 686
- References
- 70
- Citations by year
- 2026: 29 · 2025: 33 · 2024: 27 · 2023: 22 · 2022: 30 · 2021: 38 · 2020: 54 · 2019: 46 · 2018: 49 · 2017: 46 · 2016: 50 · 2015: 51 · 2014: 61 · 2013: 54 · 2012: 50
- FWCI
- 32.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- DZNE Pub (submittedVersion)
- Funders
- European Commission
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- amyloid-beta oligomers, Alzheimer's disease, tau phosphorylation, dendrites, microtubule destabilization, dendritic spines, neurofilaments, mitochondria, paclitaxel, p70S6K, cyclin-dependent kinase 5, hippocampal neurons, axonal transport, oxidative stress, glutamate, serum deprivation
- MeSH terms
- Adenosine Triphosphate, Analysis of Variance, Animals, Calcium, Cells, Cultured, Dendrites, Embryo, Mammalian, Hippocampus, L-Lactate Dehydrogenase, Microtubules, Mitochondria, Neurons, Peptide Fragments, Phosphorylation, Protein Kinases, Time Factors, Amyloid beta-Peptides, tau Proteins, Neurofilament Proteins, Rats, Sprague-Dawley, Protein Transport, Microscopy, Electron, Transmission, Dendritic Spines, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review